-
681
The Transcription Factor SOX18 Inhibitor Small Molecule 4 Is a Potential Treatment of Cancer‐Induced Lymphatic Metastasis and Lymphangiosarcoma
Published 2025-01-01Subjects: Get full text
Article -
682
Hybridization-based discovery of novel quinazoline-2-indolinone derivatives as potent and selective PI3Kα inhibitors
Published 2025-02-01Subjects: Get full text
Article -
683
Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer
Published 2025-03-01Subjects: Get full text
Article -
684
Beyond the Swell: Decoding the Enigma of Bilateral Hand Angioedema in Response to Sacubitril–valsartan Therapy
Published 2024-10-01Subjects: “…angiotensin receptor neprilysin inhibitor…”
Get full text
Article -
685
-
686
-
687
Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors
Published 2025-01-01Subjects: Get full text
Article -
688
-
689
-
690
A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitor
Published 2025-02-01Subjects: Get full text
Article -
691
A cost-utility analysis of adding SGLT2 inhibitors for the management of type 2 diabetes with chronic kidney disease in Thailand
Published 2025-01-01Subjects: Get full text
Article -
692
Rechallenge therapy versus tyrosine kinase inhibitor (TKI) for advanced metastatic colorectal cancer: a retrospective study
Published 2025-02-01Subjects: “…Tyrosine kinase inhibitor…”
Get full text
Article -
693
-
694
-
695
Cardiovascular safety of Janus kinase inhibitors in inflammatory bowel disease: a systematic review and network meta-analysis
Published 2025-12-01Subjects: Get full text
Article -
696
-
697
Antiedemic Effect of the Myosin Light Chain Kinase Inhibitor PIK7 in the Rat Model of Myocardial Ischemia Reperfusion Injury
Published 2025-01-01Subjects: Get full text
Article -
698
Bone marrow mesenchymal stem cells derived cytokines associated with AKT/IAPs signaling ameliorate Alzheimer’s disease development
Published 2025-01-01Subjects: Get full text
Article -
699
The road ahead: emerging therapies for primary IgA nephropathy
Published 2025-02-01Subjects: “…SGLT2 (sodium-glucose cotransporter 2) inhibitor…”
Get full text
Article -
700
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
Published 2025-01-01Subjects: Get full text
Article